Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

Key takeawaysIn early studies, the blood test, developed by UCLA scientists, shows promise in detecting multiple cancers.The ...

Cancer cells may be exploiting a common antioxidant as fuel, revealing a potential weakness that future therapies could ...

Newly uncloaked Stipple Bio is connecting the dots toward multiple early-stage clinical studies for its lead precision ...

Scientists in Canada have uncovered a surprising weakness in glioblastoma, one of the deadliest brain cancers. They found ...

Spread the loveA recent study has sparked significant concern within the scientific community regarding the use of Vitamin B3 supplements, particularly those that boost NAD+ (Nicotinamide Adenine ...

Drs. Yunda Huang, Maria Lemos, Bo Zhang and Karsten Eichholz were recently awarded coveted R01 grants from the National ...

The FDA has granted Fast Track Designation to CTIM-76, a claudin-6 (CLDN6) x CD3 T cell engaging bispecific antibody, for the ...

Scientists have identified a hidden vulnerability inside the cells quietly driving aging, and found a way to exploit it.

Fi Novelist Who Disappeared for Decades In “What We Are Seeking,” the cult author Cameron Reed returns to show us a strange, ...

Engineered immune cells spark cancer immunotherapy hope, following metabolic by-products secreted by cancer cells to ...

Vladimir Zharov introduces a clinically proven revolutionary early non-invasive diagnosis of cancer, infections, stroke and ...